|
Volumn 25, Issue 6, 2006, Pages 758-761
|
Clinical significance of survivin expression in peripheral T-cell lymphoma
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIRC5 PROTEIN, HUMAN;
CHOP PROTOCOL;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MICROTUBULE ASSOCIATED PROTEIN;
PREDNISONE;
VINCRISTINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
FEMALE;
FOLLOW UP;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PERIPHERAL T CELL LYMPHOMA;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
REMISSION;
SURVIVAL RATE;
TUMOR RECURRENCE;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
FOLLOW-UP STUDIES;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LYMPHOMA, T-CELL, PERIPHERAL;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PREDNISONE;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
REMISSION INDUCTION;
SURVIVAL RATE;
VINCRISTINE;
YOUNG ADULT;
|
EID: 38949186788
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|